Disc Medicine (IRON) Change in Cash (2020 - 2026)

Disc Medicine (IRON) has reported Change in Cash for 7 consecutive years, with $9.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Cash rose 109.37% year-over-year to $9.8 million; the TTM figure through Jun 2026 stood at -$28.7 million (up 81.31% YoY), while the FY2025 annual figure was -$101.3 million, up 39.69% from the prior year.
• Change in Cash grew to $9.8 million in Q2 2026 per IRON's latest filing, from -$2.2 million in the prior quarter.
• Across five years, Change in Cash topped out at $141.1 million in Q2 2023 and bottomed at -$88.0 million in Q3 2024.
• Historically, Change in Cash has averaged $594722.2 across 5 years, with a median of -$4.6 million in 2023.
• Annual changes were most pronounced in 2023 — Change in Cash surged 485.36% — and 2025, when it sank 24413.37%.
• Disc Medicine's Change in Cash stood at $139.1 million in 2022, then sank by 107.22% to -$10.0 million in 2023, then jumped by 97.99% to -$202000.0 in 2024, then tumbled by 24413.37% to -$49.5 million in 2025, then surged by 119.72% to $9.8 million in 2026.
• Business Quant data shows IRON's Change in Cash at $9.8 million in Q2 2026, -$2.2 million in Q1 2026, and -$49.5 million in Q4 2025.